10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001035267-20-000122`
Period End Date	20200630
Filing Date	20200723
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	isrg-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 72 Cash Flow Statement 70

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.17B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.04B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.05B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.45B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$508.80M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$645.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$595.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$645.50M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	116.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.00M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$256.40M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$200.20M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	116.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.90B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.66B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.45B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.62B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.59B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$425.60M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$365.50M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$465.50M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$441.40M	USD	Point-in-time
Goodwill	`Goodwill`	$307.20M	USD	Point-in-time
Goodwill	`Goodwill`	$336.80M	USD	Point-in-time
Total assets	`Assets`	$9.73B	USD	Point-in-time
Total assets	`Assets`	$10.10B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$108.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$123.50M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$251.60M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$168.70M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$337.80M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$343.10M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$304.10M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$317.30M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.03B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$924.80M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$412.40M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$418.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.34B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.45B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2020, and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2020, and December 31, 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.76B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.09B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.63B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.49B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$8.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.10M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-700.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-13.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$22.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$12.40M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$8.74B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$8.26B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$25.90M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$20.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.53B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.69B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.77B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.04B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$10.10B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.73B	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.10B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$852.10M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.95B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.07B	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$339.90M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$710.50M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$644.00M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$349.20M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.24B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.43B	USD	2 Qtrs
Gross profit	`GrossProfit`	$759.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$502.90M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$279.20M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$279.10M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$552.60M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$587.20M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$120.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$290.30M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$143.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$264.80M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$400.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$817.40M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$877.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$422.30M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$359.00M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$611.20M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$363.60M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$80.60M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$26.60M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$32.80M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$60.30M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$51.70M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$107.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$671.50M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$415.30M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$391.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$75.40M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$28.90M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$51.10M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$37.00M	USD	1 Quarter
Net income	`ProfitLoss`	$70.20M	USD	1 Quarter
Net income	`ProfitLoss`	$316.40M	USD	1 Quarter
Net income	`ProfitLoss`	$386.40M	USD	2 Qtrs
Net income	`ProfitLoss`	$620.40M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.40M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.90M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.20M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.90M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$318.30M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$624.80M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$381.50M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$68.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.27	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.76	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.42	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.58	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.57	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.19	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.67	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.23	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.80M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.40M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.40M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.70M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.70M	shares	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$335.10M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$391.40M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$654.20M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$81.40M	USD	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$386.40M	USD	2 Qtrs
Net income	`ProfitLoss`	$620.40M	USD	2 Qtrs
Net income	`ProfitLoss`	$70.20M	USD	1 Quarter
Net income	`ProfitLoss`	$316.40M	USD	1 Quarter
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$67.80M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$102.50M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$12.40M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$24.70M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$20.50M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.60M	USD	1 Quarter
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.40M	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.60M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.70M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.50M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$157.70M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$186.50M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$5.90M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$8.20M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-48.90M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-136.90M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$178.00M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$120.10M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$89.20M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$95.50M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.60M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.70M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-83.00M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-33.30M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$8.70M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$4.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-53.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-14.50M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$582.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$649.20M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.82B	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.43B	USD	2 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$800.70M	USD	2 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$61.10M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.30B	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.42B	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$215.20M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$196.90M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$37.70M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-1.20M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$419.60M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-531.60M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$154.00M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$119.60M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$145.00M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$155.10M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$100.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$200.00M	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$10.00M	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	2 Qtrs
Payment of deferred purchase consideration	`ProceedsFromPaymentsForOtherFinancingActivities`	$-30.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-220.40M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-131.10M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.30M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.60M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$869.60M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-104.10M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$805.30M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$805.30M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.05B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.18B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.